These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3787000)

  • 1. Sample sizes for phase II and phase III clinical trials: an integrated approach.
    Whitehead J
    Stat Med; 1986; 5(5):459-64. PubMed ID: 3787000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A design for phase II testing of anticancer agents within a phase III clinical trial.
    Schaid DJ; Ingle JN; Wieand S; Ahmann DL
    Control Clin Trials; 1988 Jun; 9(2):107-18. PubMed ID: 3396362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of titration studies in phase III clinical trials.
    Shih WJ; Gould AL; Hwang IK
    Stat Med; 1989 May; 8(5):583-91. PubMed ID: 2727477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing phase II studies in the context of a programme of clinical research.
    Whitehead J
    Biometrics; 1985 Jun; 41(2):373-83. PubMed ID: 4027320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confidence intervals following group sequential tests.
    Chang MN; O'Brien PC
    Control Clin Trials; 1986 Mar; 7(1):18-26. PubMed ID: 3956209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size planning for phase II trials based on success probabilities for phase III.
    Götte H; Schüler A; Kirchner M; Kieser M
    Pharm Stat; 2015; 14(6):515-24. PubMed ID: 26412484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible multi-stage design for phase II oncology trials.
    Tan MT; Xiong X
    Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical challenges in assessing potential efficacy of complex interventions in pilot or feasibility studies.
    Wilson DT; Walwyn RE; Brown J; Farrin AJ; Brown SR
    Stat Methods Med Res; 2016 Jun; 25(3):997-1009. PubMed ID: 26071430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
    Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G
    Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trials: use of a clinical tumor panel and overview of current resources and studies.
    Muggia FM; Rozencweig M; Chiuten DF; Jensen-Akula MS; Charles LM; Kubota TT; Bono VH
    Cancer Treat Rep; 1980 Jan; 64(1):1-9. PubMed ID: 6991100
    [No Abstract]   [Full Text] [Related]  

  • 11. Planned versus attained design in phase II clinical trials.
    Green SJ; Dahlberg S
    Stat Med; 1992 May; 11(7):853-62. PubMed ID: 1604065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bayesian approach to the design of phase II clinical trials.
    Sylvester RJ
    Biometrics; 1988 Sep; 44(3):823-36. PubMed ID: 3203131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies.
    Lang FF; Gilbert MR; Puduvalli VK; Weinberg J; Levin VA; Yung WK; Sawaya R; Fuller GN; Conrad CA
    Neuro Oncol; 2002 Oct; 4(4):268-77. PubMed ID: 12356357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs.
    Patel NR; Ankolekar S
    Stat Med; 2007 Nov; 26(27):4976-88. PubMed ID: 17579924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of drugs used in fertility regulation.
    Siemens AJ
    Hum Reprod; 1986 Sep; 1(6):405-10. PubMed ID: 3104401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
    BioDrugs; 2003; 17(1):69-72. PubMed ID: 12534322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-theoretic designs for small trials and pilot studies: A review.
    Hee SW; Hamborg T; Day S; Madan J; Miller F; Posch M; Zohar S; Stallard N
    Stat Methods Med Res; 2016 Jun; 25(3):1022-38. PubMed ID: 26048902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.